TauroLock™-U25.000
Proven Protection for Catheter Care
Triple-Action Protection for High-Risk Catheters
TauroLock™-U25.000 is an antimicrobial and fibrinolytic citrate catheter lock solution, combining taurolidine, 4% citrate, and urokinase (25,000 IU). This triple-action formulation provides enhanced protection against catheter-related complications by helping to prevent infection, maintain line patency and reduce the need for thrombolytic rescue therapies. Each 5 mL dose is reconstituted using one ampoule (taurolidine + citrate) and one vial of lyophilised urokinase. The solution is instilled into the catheter between treatments to lock the line.
TauroLock™-U25.000 is particularly suited for patients with a history of catheter occlusion, those transitioning from alteplase, or where line salvage and ongoing maintenance are critical. While not intended as treatment for occlusions, it is generally recommended as a prophylactic lock for the prevention of infection and fibrin build-up.
Routine use has been associated with significant cost savings in medical supplies budgets, dramatically reducing the need for alteplase, catheter replacements, and unplanned hospital admissions.
More Information
TauroLock™-U25.000
Available in:
Pack size: 5 ampoules + 5 vials (TP-05)
Each dose contains:
- 1 x 5 mL glass ampoule (taurolidine + 4% citrate)
- 1 x vial of freeze-dried urokinase (25,000 IU)
Key Benefits of TauroLock™-U25.000
To explore the full benefits of TauroLock™-U25.000 and how it can support high-risk catheter management, download the product brochure or visit the TauroPharm website for more information.
For a customised product education session or to discuss catheter-related issues, contact Prima MediPharm today. We’re here to offer expert guidance with your questions and help you place your order.
